Ginkgo Bioworks
DNA
DNA
165 hedge funds and large institutions have $319M invested in Ginkgo Bioworks in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
10.82% more ownership
Funds ownership: 61.09% → 71.91% (+11%)
5% more funds holding
Funds holding: 157 → 165 (+8)
8% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 39
Holders
165
Holding in Top 10
3
Calls
$29.6M
Puts
$7.59M
Top Buyers
| 1 | +$32.8M | |
| 2 | +$17.1M | |
| 3 | +$5.66M | |
| 4 |
Millennium Management
New York
|
+$5.14M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.73M |
Top Sellers
| 1 | -$5.82M | |
| 2 | -$5.65M | |
| 3 | -$4.56M | |
| 4 |
D.E. Shaw & Co
New York
|
-$3.2M |
| 5 |
GCM
Glenview Capital Management
New York
|
-$2.82M |